Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a new nerve block ease shoulder pain without affecting breathing?

NCT ID NCT07739303

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial compares two ways to numb the shoulder for surgery: the standard interscalene block and a combination of two other nerve blocks. The goal is to see if the combination provides similar pain relief while better preserving diaphragm function, which is important for breathing. Adults aged 18-65 having arthroscopic shoulder surgery will be randomly assigned to one of the two blocks, and their pain and breathing will be measured after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Two nerve block procedures: an interscalene block or a combination of anterior suprascapular and axillary nerve blocks, both using bupivacaine.
What this could lead to
If the combined nerve block works as well as the standard one, it could offer a safer way to manage shoulder surgery pain with less impact on breathing.
What could go wrong
This is a small, early-stage trial, so results may not apply to everyone. The combined block might not provide pain relief as effective as the standard approach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged between 18 and 65 years * American Society of Anesthesiologists (ASA) physical status I, II, or III * Patients scheduled to undergo elective arthroscopic shoulder surgery * BMI between 18 and 30 kg/m2 * Ability to provide written informed consent Exclusion Criteria: * Known allergy or hypersensitivity to local anesthetics * Presence of localized infection at the planned injection site * Severe coagulopathy or active use of anticoagulant medications * Contralateral phrenic nerve palsy or a diagnosis of severe chronic obstructive pulmonary disease (COPD) * History of chronic opioid consumption or neuropathic pain

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diaphragm protective block are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ankara Etlik City Hospital

    RECRUITING

    Yenimahalle, Ankara, 06170, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.